Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) and Provides Progress Update on COVID-19 antibody tests

Stock Information for Biomerica Inc.

Loading

Please wait while we load your information from QuoteMedia.